-
Scientific Outcome of ISPOR Conferences: An Analysis of 67,055 Abstracts Presented at 54 ISPOR Conferences Between 2002-2024
Sep 9, 2025, 16:22 PM -
From Deficit Risk to Surplus Strength: A Revenue-Centered Analysis of Türkiye’s General Health Insurance 2015-2024
Sep 9, 2025, 16:22 PM -
Effect of Education Given to Nursing Students on Their Palliative Care Knowledge and Attitudes
Sep 9, 2025, 16:22 PM -
Patient Pathways to Accessing Unregistered Medicines in Low-Priority Launch Markets
Sep 9, 2025, 16:22 PM -
Matching-Adjusted Indirect Comparison Between Garadacimab and Donidalorsen for Long-Term Prophylaxis in Hereditary Angioedema
Sep 9, 2025, 16:22 PM -
Evolving Payer Preferences for Health Economic Information and Communication in the US
Sep 9, 2025, 16:22 PM -
Integrating Real-World Evidence Into Oncology HTA Submissions: Recent EU Examples
Sep 9, 2025, 16:22 PM -
Hidden Obesity and Treatment Gaps in Japan: A Real-World Data Analysis
Sep 9, 2025, 16:22 PM -
Accelerating RTOR in Oncology: The AIM Model for Agile Trial Operations
Sep 9, 2025, 16:22 PM -
The New Avenue for Access? European Market Access Routes Outside Traditional Public Payer Pathways
Sep 9, 2025, 16:22 PM -
Receipt of Biomarker Testing in Non-Small Cell Lung Cancer: Using Real-World Data to Identify Testing Gaps and Treatment Characteristics
Sep 9, 2025, 16:22 PM -
Prediction of Query Outcomes in the Setting of Observational Studies
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis of the AlloMap® Test for the Monitoring of Patients After Heart Transplantation: Economic Evaluation Alongside the CUPIDON Trial
Sep 9, 2025, 16:22 PM -
High Entry Costs Slower Growth: A Nationwide Register Study on Newly Reimbursed Biologic Medicines in Finland 2011-2021
Sep 9, 2025, 16:22 PM -
Treatment Patterns, Inadequate Disease Control, and Burden/Unmet Need Among Adult Patients With Moderate-to-Severe Atopic Dermatitis: Results From the Adelphi Real-World Disease Specific Program
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of High-Energy High-Protein (HEHP) Oral Nutritional Support (ONS) for the Treatment of Disease-Related Malnutrition (DRM) in Cancer Patients in the French Community Setting
Sep 9, 2025, 16:22 PM -
Health-Related Quality of Life Following Administration of Influenza and COVID-19 Combination Vaccine in Older Adults: Results From a Phase 3 Randomized Controlled Trial
Sep 9, 2025, 16:22 PM -
Reducing Premature Cancer Mortality Through Early Stage Treatment: A Markov Model Analysis of Pembrolizumab Across Four Tumor Types
Sep 9, 2025, 16:22 PM -
Confidential Prices in NICE Health Technology Assessment: How Common Are They?
Sep 9, 2025, 16:22 PM -
Germany: Still a Benchmark for ATMP Access and Pricing: A Pricing Analysis of Germany's ATMP Landscape Compared to Other European Countries
Sep 9, 2025, 16:22 PM
